Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · December 28, 2021

Infusional Fluorouracil, Leucovorin, and Oxaliplatin Improve Survival Outcomes in Advanced HCC

Journal of Clinical Oncology


Additional Info

Journal of Clinical Oncology
Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1)
J. Clin. Oncol 2021 Dec 14;[EPub Ahead of Print], N Lyu, X Wang, JB Li, JF Lai, QF Chen, SL Li, HJ Deng, M He, LW Mu, M Zhao

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading